DCGI approves advanced trials for Biological E. Limited’s COVID-19 vaccine
June 7, 2023
  • Circulation
  • Advertise
  • Careers
  • About Us
  • Contact Us
Organiser
  • ‌
  • Bharat
  • World
  • G20
  • Editorial
  • Analysis
  • Opinion
  • Sports
  • More
    • Defence
    • RSS in News
    • Azadi Ka Amrit Mahotsav
    • My States
    • Vocal4Local
    • Business
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
    • Podcast
SUBSCRIBE
No Result
View All Result
  • ‌
  • Bharat
  • World
  • G20
  • Editorial
  • Analysis
  • Opinion
  • Sports
  • More
    • Defence
    • RSS in News
    • Azadi Ka Amrit Mahotsav
    • My States
    • Vocal4Local
    • Business
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
    • Podcast
No Result
View All Result
Organiser
No Result
View All Result
  • Home
  • Bharat
  • World
  • G20
  • Editorial
  • Opinion
  • Analysis
  • Culture
  • Defence
  • RSS in News
  • My States
  • Vocal4Local
  • Subscribe
Home Bharat

DCGI approves advanced trials for Biological E. Limited’s COVID-19 vaccine

WEB DESK by WEB DESK
Sep 4, 2021, 02:11 pm IST
in Bharat
Share on FacebookShare on TwitterTelegramEmail
The Department of Biotechnology and Biotechnology Industry Research Assistance Council have supported Biological E.’s COVID-19 Vaccine candidate from the preclinical stage.

 

New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator safety and immunogenicity trial in adults of its CORBEVAX™ vaccine against COVID-19 after Subject Expert Committee’s (SEC) review of Phase I and II clinical trials data.

This follows the approval given to the company on September 1 to initiate the Phase II/III Study to evaluate the safety, reactogenicity, tolerability, and immunogenicity of the vaccine in children and adolescents. The candidate vaccine is an RBD protein subunit vaccine.
Welcoming the approval, Dr. Renu Swarup, Secretary, Department of Biotechnology (DBT) and Chairman of its public sector undertaking, Biotechnology Industry Research Assistance Council (BIRAC), said, “Department of Biotechnology through Mission COVID Suraksha launched under Atma Nirbhar Bharat package 3.0 being implemented by BIRAC, is committed to the development of safe and efficacious COVID-19 vaccines. We look forward to the clinical development of candidate CORBEVAX™ for paediatric and adults.”

Ms Mahima Datla, Managing Director, Biological E. Limited, said-“We are delighted to receive these significant approvals from the DCGI. These approvals encourage our organisation to move forward and successfully produce our COVID-19 vaccine to meet the vaccination needs. We are grateful to BIRAC for their support, and we are enthused that these approvals would help support our subsequent filings with WHO as well. We appreciate and acknowledge the contribution of all our collaborators for their continued support in this endeavour.’’

The Department of Biotechnology has taken several initiatives to increase investments in research & development (R&D) and the manufacture of COVID-19 Vaccines. The establishment of the Mission COVID Suraksha Program is one such endeavour for COVID-19 vaccine development to reinforce and streamline available resources towards accelerated vaccine development, leading to bringing in a safe, efficacious, affordable, and accessible COVID-19 Vaccine for the citizens at the earliest with a target of Atmanirbhar Bharat.

The Department of Biotechnology and Biotechnology Industry Research Assistance Council have supported Biological E.’s COVID-19 Vaccine candidate from the preclinical stage. In addition to receiving financial assistance under Mission COVID Suraksha, this vaccine candidate has also obtained financial support under COVID-19 Research Consortia through the National Biopharma Mission of BIRAC.

Courtesy: India Science Wire

ShareTweetSendShareSend
Previous News

Scientists develop a device to grow microorganisms in outer space

Next News

New mechanised scavenging system to tackle diverse sewerage chokages

Related News

Can exercise reduce a person’s genetic susceptibility to disease?

Can exercise reduce a person’s genetic susceptibility to disease?

Microsoft says disrupted Chinese hacking group targeting organizations worldwide

US: allegations against Microsoft of violating children’s privacy; Federal Trade Commission asks to pay $20 million

Gujarat: PM Modi’s school to be developed as ‘Prerna’ as part of Mega Vadnagar Development Plan

Gujarat: PM Modi’s school to be developed as ‘Prerna’ as part of Mega Vadnagar Development Plan

Assam: Jaramkhuria to be converted to zero-waste village, third village in country to receive this tag

Assam: Jaramkhuria to be converted to zero-waste village, third village in country to receive this tag

NCB busts pan-India drug network that used darknet, cryptocurrency; 6 held, largest haul in 2 decades

NCB busts pan-India drug network that used darknet, cryptocurrency; 6 held, largest haul in 2 decades

Heard of Game Jihad? Here are detail of how three Hindus & a Jain boy started offering Namaz while playing online game

Heard of Game Jihad? Here are detail of how three Hindus & a Jain boy started offering Namaz while playing online game

Comments

The comments posted here/below/in the given space are not on behalf of Organiser. The person posting the comment will be in sole ownership of its responsibility. According to the central government's IT rules, obscene or offensive statement made against a person, religion, community or nation is a punishable offense, and legal action would be taken against people who indulge in such activities.

Latest News

Can exercise reduce a person’s genetic susceptibility to disease?

Can exercise reduce a person’s genetic susceptibility to disease?

Microsoft says disrupted Chinese hacking group targeting organizations worldwide

US: allegations against Microsoft of violating children’s privacy; Federal Trade Commission asks to pay $20 million

Gujarat: PM Modi’s school to be developed as ‘Prerna’ as part of Mega Vadnagar Development Plan

Gujarat: PM Modi’s school to be developed as ‘Prerna’ as part of Mega Vadnagar Development Plan

Assam: Jaramkhuria to be converted to zero-waste village, third village in country to receive this tag

Assam: Jaramkhuria to be converted to zero-waste village, third village in country to receive this tag

NCB busts pan-India drug network that used darknet, cryptocurrency; 6 held, largest haul in 2 decades

NCB busts pan-India drug network that used darknet, cryptocurrency; 6 held, largest haul in 2 decades

Heard of Game Jihad? Here are detail of how three Hindus & a Jain boy started offering Namaz while playing online game

Heard of Game Jihad? Here are detail of how three Hindus & a Jain boy started offering Namaz while playing online game

The ‘Supreme’ and the ‘Supremer’

The ‘Supreme’ and the ‘Supremer’

Uttarkashi: Massive protests against abduction of Hindu girl; posters asking Muslim owners to vacate shops installed

Uttarkashi: Massive protests against abduction of Hindu girl; posters asking Muslim owners to vacate shops installed

Nepal and India should hold talks to resolve border issue: PM Prachanda

Nepal and India should hold talks to resolve border issue: PM Prachanda

Aranmula Mirrors, India’s wonder artefact, face a serious threat from climate change

Aranmula Mirrors, India’s wonder artefact, face a serious threat from climate change

  • Privacy
  • Terms
  • Cookie Policy
  • Refund and Cancellation
  • Delivery and Shipping

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

No Result
View All Result
  • Home
  • Bharat
  • World
  • Editorial
  • Analysis
  • Opinion
  • Defence
  • Culture
  • Sports
  • Business
  • RSS in News
  • My States
  • Vocal4Local
  • Special Report
  • Sci & Tech
  • Entertainment
  • Education
  • Books
  • Interviews
  • Travel
  • Health
  • Obituary
  • Podcast
  • Subscribe
  • Advertise
  • Circulation
  • Careers
  • About Us
  • Contact Us
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Refund and Cancellation

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies